About the Company
Ligand Pharmaceuticals is a biopharmaceutical company located in San Diego, California. Founded in 1987 as Progenix Inc., the company went public in 1992. Initially focused on developing its own drugs, a period of turbulence in the early 2000s culminated in its CEO being ejected by the shareholders and provoked a change in focus to the acquisition of existing drugs and forming partnerships to develop them further.The company has been the subject of multiple regulatory investigations, negative shorts-seller reports and class action lawsuits amid allegations of securities fraud.In 2018 its CEO was listed among the top five highest paid CEOs in San Diego.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $LGND News
Ligand Pharmaceuticals gets grant for imidazole-fused heterocycle compounds for treating leukemia
Discover Ligand Pharmaceuticals Inc's groundbreaking patent for compounds treating leukemia and hematopoietic disorders. Explore the innovative Formula (III) and pharmaceutical compositions for ...
Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMI(TM)
Ligand Pharmaceuticals (Nasdaq: LGND ... the rights to ZELSUVMI and all the assets related to the NITRICIL technology platform from Novan, Inc. in September 2023. “ZELSUVMI is a highly differentiated ...
LGNZZ Ligand Pharmaceuticals Incorporated TR BET CONT RT
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, engages in the development and licensing of biopharmaceutical assets worldwide. Its commercial programs include Kyprolis and ...
Ligand Pharmaceuticals Incorporated (LGND)
LONDON, April 08, 2024--Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its partners at the University of Minnesota (UMN) and CURx Pharmaceuticals, Inc. presented new data ...
At Ligand Pharmaceuticals, Todd C Davis Chooses To Exercise Options, Resulting In $252K
This values Davis's 16,015 shares at $252,004. About Ligand Pharmaceuticals Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in ...
Ligand Pharmaceuticals Inc LGND
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMI™
DURHAM, N.C., April 03, 2024--(BUSINESS WIRE)--Ligand Pharmaceuticals (Nasdaq ... to the NITRICIL technology platform from Novan, Inc. in September 2023. "ZELSUVMI is a highly differentiated ...
Ligand Pharmaceuticals Inc LGND
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Ligand Pharmaceuticals Inc.
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
Loading the latest forecasts...